跳至主要内容
临床试验/NL-OMON38792
NL-OMON38792已完成不适用

Effect of Fecal transplant harvested from Bariatric surgery subjects on Lipid and Glucose metabolism in subjects with metabolic syndrome; - FEBALIGO study

Academisch Medisch Centrum0 个研究点目标入组 33 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
33

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • Meeting the criteria for metabolic syndrome (ATP-III criteria)
  • No relevant (confounding) comorbidity or medication use;Feces donors post-RYGB:
  • +- 1 year after gastric bypass with significant weight loss
  • No relevant (confounding) comorbidity
  • free of transmissible diseases upon screening;Feces donors pre-RYGB:
  • Scheduled for gastric bypass (RYGB)
  • No relevant (confounding) comorbidity
  • free of transmissible diseases upon screening

排除标准

  • relevant comorbidity
  • additional medication use except when directly related to metabolic syndrome
  • antibiotic use in the last 3 months;Feces donors (pre- and post-RYGB):
  • relevant morbidity
  • medication use
  • PPI or antibiotic use in the last 3 months
  • frequent patient contact

研究者

相似试验